Statement: FDA Must Reject Tanezumab as a Treatment for Osteoarthritis Due to Unacceptable Dangers, Little to No Benefit
CAFTA Investor Rights Undermining Democracy and the Environment: Commerce Group Case November 15, 2012
CAFTA Investor Rights Undermining Democracy and the Environment: Pacific Rim Mining Case May 26, 2010